Related Experiment Video
Updated: May 25, 2026
10:02
Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Triterpenoids from Ganoderma lucidum and their cytotoxic activities
Peng Li1, Yan-Ping Deng, Xiao-Xia Wei
1Fujian Provincial Key Laboratory of Pharmacology of Natural Medicine, School of Pharmacy, Fujian Medical University, Fuzhou 350004, China.
Natural Product Research
|January 24, 2012
Summary
A new triterpenoid, ethyl lucidenates A, was isolated from Ganoderma lucidum. This compound and others showed cytotoxic activity against specific cancer cell lines in vitro.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Ganoderma lucidum (Reishi mushroom) is a traditional medicinal fungus.
- Triterpenoids from Ganoderma lucidum are known for diverse biological activities.
- Investigating novel compounds from G. lucidum is crucial for drug discovery.
Purpose of the Study:
- To isolate and characterize new and known compounds from the ethyl acetate fraction of Ganoderma lucidum.
- To evaluate the in vitro cytotoxic activities of the isolated compounds against various human cancer cell lines.
Main Methods:
- Isolation of compounds using silica gel column chromatography, ODS column chromatography, and preparative High-Performance Liquid Chromatography (PHPLC).
- Structure elucidation based on comprehensive spectroscopic analysis (NMR, MS) and chemical evidence.
- In vitro cytotoxic activity assessment using the MTT assay.
Main Results:
- A new triterpenoid, ethyl lucidenates A (compound 4), was identified.
- Three known compounds: ganodermanondiol (1), lucidumol B (2), and methyl lucidenates A (3) were also isolated.
- Ethyl lucidenates A exhibited significant cytotoxicity against HL-60 and CA46 cancer cell lines, with IC50 values of 25.98 µg/mL and 20.42 µg/mL, respectively.
Conclusions:
- Ethyl lucidenates A is a novel cytotoxic triterpenoid isolated from Ganoderma lucidum.
- The findings suggest potential therapeutic applications of Ganoderma lucidum-derived compounds in cancer treatment.
- Further research is warranted to explore the mechanism of action and optimize the efficacy of these compounds.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...